The Complex Relationship Between Cannabis Use and Mental Health: Considering the Influence of Cannabis Use Patterns and Individual Factors
CNS Drugs · 2025
DOI: 10.1007/s40263-024-01148-2 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift CNS Drugs, 2025. Verfasst von Kelly A Sagar und 1 weiteren Autor:innen. Beteiligte Einrichtung: Cognitive and Clinical Neuroimaging Core, McLean Hospital, McLean Imaging Center, Belmont, MA, USA. ksagar@mclean.harvard.edu. Hauptthemen laut MEDLINE: Mental Disorders, Mental Health, Marijuana Use, Cannabis. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 151 Literaturangaben. Gefördert von: Intramural Research Program, National Institute on Drug Abuse.
Abstract (Originalsprache)
The relationship between cannabis use and mental health is complex, as studies often report seemingly contradictory findings regarding whether cannabis use results in more positive or negative treatment outcomes. With an increasing number of individuals using cannabis for both recreational (i.e., non-medical) and medical purposes, it is critical to gain a deeper understanding of the ways in which cannabis may be helpful or harmful for those diagnosed with psychiatric disorders. Although cannabis is composed of hundreds of compounds, studies assessing the effects of "cannabis" most often report the impact of delta-9-tetrahydrocannabinol (d9-THC), the primary intoxicating constituent of the plant. While d9-THC has documented therapeutic properties, negative clinical outcomes commonly associated with cannabis are generally related to d9-THC exposure. In contrast, non-intoxicating cannabinoids such as cannabidiol (CBD) show promise as potential treatment options for psychiatric symptoms. In this article, findings from studies and reviews examining the relationship between mental health conditions (mood, anxiety, psychosis, and post-traumatic stress disorder [PTSD]) and cannabis use are summarized to highlight critical variables that are often overlooked, including those associated with cannabis use patterns (e.g., frequency of use, amount used, cannabinoid exposure, product choice, and route of administration). Further, this article explores individual factors (e.g., age, sex, genetics/family history) that likely impact cannabis-related outcomes. Research to date suggests that youth and those with a family history or genetic liability for psychiatric disorders are at higher risk for negative outcomes, while more research is needed to fully understand unique effects related to sex and older age.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Cognitive and Clinical Neuroimaging Core, McLean Hospital, McLean Imaging Center, Belmont, MA, USA. ksagar@mclean.harvard.edu.
- Marijuana Investigations for Neuroscientific Discovery (MIND) Program, McLean Hospital, Belmont, MA, USA. ksagar@mclean.harvard.edu.
- Department of Psychiatry, Harvard Medical School, Boston, MA, USA. ksagar@mclean.harvard.edu.
- Cognitive and Clinical Neuroimaging Core, McLean Hospital, McLean Imaging Center, Belmont, MA, USA.
- Marijuana Investigations for Neuroscientific Discovery (MIND) Program, McLean Hospital, Belmont, MA, USA.
- Department of Psychiatry, Harvard Medical School, Boston, MA, USA.
ORCID-Profile: Kelly A Sagar, Staci A Gruber
Förderung
- Intramural Research Program, National Institute on Drug Abuse
Zitieren
APA
Sagar, K. A., & Gruber, S. A. (2025). The Complex Relationship Between Cannabis Use and Mental Health: Considering the Influence of Cannabis Use Patterns and Individual Factors. CNS Drugs. https://doi.org/10.1007/s40263-024-01148-2
Vancouver
Sagar KA, Gruber SA. The Complex Relationship Between Cannabis Use and Mental Health: Considering the Influence of Cannabis Use Patterns and Individual Factors. CNS Drugs. 2025. doi:10.1007/s40263-024-01148-2
BibTeX
@article{Sagar2025,
author = {Sagar, Kelly A and Gruber, Staci A},
title = {The Complex Relationship Between Cannabis Use and Mental Health: Considering the Influence of Cannabis Use Patterns and Individual Factors},
journal = {CNS Drugs},
year = {2025},
doi = {10.1007/s40263-024-01148-2}
}
EUVIMED